Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

M Willis, O Pearson, Zsolt Illés, C Nielsen, Tobias Sejbæk Mathiesen, Martin Duddy, K Petheram, C van Munster, J Killestein, B Uitdehaag, C Malmestrom, E Tallantyre, N Robertson

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date14. Sep 2016
Publication statusPublished - 14. Sep 2016
Event32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, United Kingdom
Duration: 14. Sep 201617. Sep 2016

Conference

Conference32nd ECTRIMS
LocationExCeL London
CountryUnited Kingdom
CityLondon
Period14/09/201617/09/2016

Cite this

Willis, M., Pearson, O., Illés, Z., Nielsen, C., Mathiesen, T. S., Duddy, M., ... Robertson, N. (2016). Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. Poster session presented at 32nd ECTRIMS, London, United Kingdom.
Willis, M ; Pearson, O ; Illés, Zsolt ; Nielsen, C ; Mathiesen, Tobias Sejbæk ; Duddy, Martin ; Petheram, K ; van Munster, C ; Killestein, J ; Uitdehaag, B ; Malmestrom, C ; Tallantyre, E ; Robertson, N. / Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. Poster session presented at 32nd ECTRIMS, London, United Kingdom.
@conference{4dba586009694181b43616eacf287fcf,
title = "Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab",
author = "M Willis and O Pearson and Zsolt Ill{\'e}s and C Nielsen and Mathiesen, {Tobias Sejb{\ae}k} and Martin Duddy and K Petheram and {van Munster}, C and J Killestein and B Uitdehaag and C Malmestrom and E Tallantyre and N Robertson",
year = "2016",
month = "9",
day = "14",
language = "English",
note = "null ; Conference date: 14-09-2016 Through 17-09-2016",

}

Willis, M, Pearson, O, Illés, Z, Nielsen, C, Mathiesen, TS, Duddy, M, Petheram, K, van Munster, C, Killestein, J, Uitdehaag, B, Malmestrom, C, Tallantyre, E & Robertson, N 2016, 'Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab', 32nd ECTRIMS, London, United Kingdom, 14/09/2016 - 17/09/2016.

Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. / Willis, M; Pearson, O; Illés, Zsolt; Nielsen, C; Mathiesen, Tobias Sejbæk ; Duddy, Martin; Petheram, K; van Munster, C; Killestein, J; Uitdehaag, B; Malmestrom, C; Tallantyre, E; Robertson, N.

2016. Poster session presented at 32nd ECTRIMS, London, United Kingdom.

Research output: Contribution to conference without publisher/journalPosterResearch

TY - CONF

T1 - Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

AU - Willis, M

AU - Pearson, O

AU - Illés, Zsolt

AU - Nielsen, C

AU - Mathiesen, Tobias Sejbæk

AU - Duddy, Martin

AU - Petheram, K

AU - van Munster, C

AU - Killestein, J

AU - Uitdehaag, B

AU - Malmestrom, C

AU - Tallantyre, E

AU - Robertson, N

PY - 2016/9/14

Y1 - 2016/9/14

M3 - Poster

ER -

Willis M, Pearson O, Illés Z, Nielsen C, Mathiesen TS, Duddy M et al. Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. 2016. Poster session presented at 32nd ECTRIMS, London, United Kingdom.